Skip to main content
ERC
News
Participate
Patients
Doctors
Investors
Products
Gliovac/ERC1671
Media
News
Publications
About
Executive Management
Executive board
Scientific board
Milestone achievements
Contact
News
Publications
15
May
2016
Approval for open phase II study
ULB Belgium’s ethical commitee has approved the protocol for an open phase II study of standard treatments in combination
with Gliovac/ERC1671/SITOIGANAP
vs...
29
Mar
2016
Interest to use our technology for other cancers
Based on the visibility of preliminary results for GBM, independent groups expressed their strong interest to use the technology for other cancers.
Pages
« first
1
2
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our
Cookie and Privacy Policy
for more details.
Close